Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States

Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution and serotype-specific resistance contributed to geographic heterogeneity of penicillin resistance.

• Publication year

  2017

• Venue

  Emerging Infectious Diseases

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3201/eid2306.161331PMID 28518018PMCID 5443431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study.

  2016cited by this paper
• Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era.

  2015cited by this paper
• Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia

  2015cited by this paper
• Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.

  2015cited by this paper
• Changes in Pneumococcal Serotypes and Antimicrobial Resistance after Introduction of the 13-Valent Conjugate Vaccine in the United States

  2014cited by this paper
• Outpatient antibiotic prescribing in the United States: 2000 to 2010

  2014cited by this paper
• Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine.

  2014influential reference
• Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts.

  2014cited by this paper
• Trends and Seasonal Variation in Outpatient Antibiotic Prescription Rates in the United States, 2006 to 2010

  2014influential reference
• Nearly Complete Elimination of the 7-valent Pneumococcal Conjugate Vaccine Serotypes in Tennessee

  2013cited by this paper
• Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States.

  2013influential reference
• Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011

  2013cited by this paper
• Pneumococcal Carriage and Invasive Disease in Children Before Introduction of the 13-valent Conjugate Vaccine: Comparison With the Era Before 7-valent Conjugate Vaccine

  2013cited by this paper
• Population genomics of post-vaccine changes in pneumococcal epidemiology

  2013cited by this paper
• Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites

  2013cited by this paper
• Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities.

  2012cited by this paper
• Serotype replacement in disease after pneumococcal vaccination.

  2011cited by this paper
• 13-valent pneumococcal conjugate vaccine (PCV13)

  2011cited by this paper
• Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination.

  2011cited by this paper
• Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.

  2011cited by this paper
• Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged ≤59 months---selected U.S. regions, 2010--2011.

  2011cited by this paper
• Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era.

  2010cited by this paper
• Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete.

  2010cited by this paper
• Changing Serotypes Causing Childhood Invasive Pneumococcal Disease: Massachusetts, 2001–2007

  2009cited by this paper
• Increased Antimicrobial Resistance Among Nonvaccine Serotypes of Streptococcus pneumoniae in the Pediatric Population After the Introduction of 7-Valent Pneumococcal Vaccine in the United States

  2007cited by this paper
• Post-PCV7 Changes in Colonizing Pneumococcal Serotypes in 16 Massachusetts Communities, 2001 and 2004

  2004cited by this paper
• Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States

  2003influential reference
• Performance standards for antimicrobial susceptibility testing

  2001cited by this paper
• Type variation of strains of Streptococcus pneumoniae in capsular serogroup 15.

  1983cited by this paper

• Impact of Antibiotic Resistance of Bacteria in Biofilms and Microbial Fuel Cell: Confronting the Dark Box for Global Health Threat

  2022cites this paper
• Streptococcus pneumoniae: a Plethora of Temperate Bacteriophages With a Role in Host Genome Rearrangement

  2021cites this paper
• Genomic epidemiology of methicillin-resistant and -susceptible Staphylococcus aureus from bloodstream infections

  2021cites this paper
• Pharmacokinetic/pharmacodynamic evaluation of the antimicrobial therapy of pneumococcal invasive disease in adults in post-PCV13 vaccine period in Madrid, Spain

  2021cites this paper
• Trends in complications of pediatric rhinosinusitis in the United States from 2006 to 2016.

  2020cites this paper
• Impact of vaccines on antimicrobial resistance.

  2020cites this paper
• Increasing non-susceptibility to antibiotics within carried pneumococcal serotypes - Alaska, 2008-2015.

  2020cites this paper
• Clonal yet Different: Understanding the Causes of Genomic Heterogeneity in Microbial Species and Impacts on Public Health

  2019cites this paper
• Impact of Antimicrobial Treatment for Acute Otitis Media on Carriage Dynamics of Penicillin-Susceptible and Penicillin-Nonsusceptible Streptococcus pneumoniae

  2018cites this paper
• Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.

  2018cites this paper
• EPIDEMIOLOGICAL ASSESSMENT OF RISK FACTORS FOR PREVALENCE OF ANTIBIOTIC-RESISTANT STRAINS OF UPPER AIRWAYS AND ENT-ORGANS INFECTIOUS PATHOGENS IN CHILDREN

  2017cites this paper
• Impact of antimicrobial treatment for acute otitis media on carriage dynamics of penicillin-susceptible and penicillin–non-susceptible Streptococcus pneumoniae: secondary analysis of a randomized, double-blind, placebo-controlled trial

  2017cites this paper
• Effect of antimicrobial treatment for acute otitis media on carriage of Streptococcus pneumoniae with reduced susceptibility to penicillin in a randomized, double-blind, placebo-controlled trial

  2017cites this paper